| Schedule of Earnings (Loss) Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Net income (loss) per share – basic |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) (thousands of U.S. dollars) |
|
$ |
17,120 |
|
|
$ |
(3,484 |
) |
|
$ |
14,906 |
|
|
$ |
(10,747 |
) |
Weighted average number of shares outstanding (thousands of shares) |
|
|
194,391 |
|
|
|
190,981 |
|
|
|
193,776 |
|
|
|
190,693 |
|
Net income (loss) per share (U.S. dollars) − basic (as on the Consolidated Statement of Operations) |
|
$ |
0.09 |
|
|
$ |
(0.02 |
) |
|
$ |
0.08 |
|
|
$ |
(0.06 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share − diluted |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) (thousands of U.S. dollars) |
|
$ |
17,120 |
|
|
$ |
(3,484 |
) |
|
$ |
14,906 |
|
|
$ |
(10,747 |
) |
Weighted average number of shares outstanding (thousands of shares) |
|
|
194,391 |
|
|
|
190,981 |
|
|
|
193,776 |
|
|
|
190,693 |
|
Dilutive RSUs (thousands of shares) (1) |
|
|
1,090 |
|
|
|
- |
|
|
|
2,961 |
|
|
|
- |
|
Dilutive New DSUs (thousands of shares) (1) |
|
|
3,334 |
|
|
|
- |
|
|
|
3,049 |
|
|
|
- |
|
Weighted average number of shares outstanding (thousands of shares) |
|
|
198,815 |
|
|
|
190,981 |
|
|
|
199,786 |
|
|
|
190,693 |
|
Net income (loss) per share (U.S. dollars) − diluted (as on the Consolidated Statement of Operations) |
|
$ |
0.09 |
|
|
$ |
(0.02 |
) |
|
$ |
0.07 |
|
|
$ |
(0.06 |
) |
(1) For the three and nine months ended September 30, 2026 the Net income per share − diluted includes the effect of 1.1 million and 3.0 million RSUs and 3.3 million and 3.0 million New DSUs, respectively, as they would have the potential to dilute basic income per share. Refer to Note 8 for the anti-dilutive impact on the three and nine months ended September 30, 2026 and the three and nine months ended September 30, 2025.
|